Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Analgesic Technique for Post-laparoscopy Pain
NCT03241602Phase 4
Key facts
- Status
- Completed
- Start
- Aug 2017
- Primary completion
- Oct 2017
- Countries
- 1
- Sponsor
- Cairo University
- Modality
- Small Molecules
- Drugs
- lidocaine
- Conditions
- postoperative pain
01
Overview
Phase 4, randomised, double-blind trial of lidocaine in postoperative pain (3 arms), sponsored by Cairo University. Primary endpoint: Postoperative pain measuring 6 hours postoperative. Started Aug 2017; status: completed.
02
Design
3 arms- Study design
- RandomizedDouble-blind
Pulmonary recruitment & Intraperitoneal lidocaine
Pulmonary recruitment maneuver + Intraperitoneal lidocaine (1.75 ml/kg of 0.2%).
Pulmonary recruitment & Intraperitoneal saline
Pulmonary recruitment maneuver + Intraperitoneal saline.
Passive exsufflation
Passive exsufflation through port site.
03
Who it enrols
Female patients aged 18-45 scheduled for diagnostic gynecologic laparoscopy with ASA I or II. Excludes patients with chronic pain, substance abuse, or recent opioid use.
04
Endpoints
Primary
Postoperative pain measuring 6 hours postoperative
Secondary
Post-operative Pain measuring Visual analogue scale 8 and 10 hour
Post-operative Nausea and Vomitting
Beyond the preview
Go deeper on NCT03241602.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03241602.